Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BY 4.0PLOS Pathogens

A feline coronavirus nucleocapsid protein disrupts ZC3HAV1–viral RNA association to counteract host RNA-level restriction

2 more authors
  1. 1Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS), Shanghai, China

Abstract

Background: Coronaviruses have evolved intricate mechanisms to evade host RNA surveillance systems and sustain efficient replication. The feline infectious peritonitis virus (FIPV), a highly lethal feline coronavirus that causes systemic vasculitis and fatal peritonitis, represents a major challenge in veterinary medicine and serves as a valuable model for studying conserved coronavirus–host interactions. Among coronavirus structural proteins, the nucleocapsid (N) protein not only packages the viral genome but also modulates host antiviral responses, yet its role in counteracting RNA restriction remains incompletely understood. Results: Using co-immunoprecipitation coupled with mass spectrometry screening, we identified the host RNA-binding antiviral factor ZC3HAV1 (also known as ZAP or PARP13) as a prominent N-associated host protein. ZC3HAV1 restricted FIPV replication by associating with viral RNA and reducing viral RNA accumulation and persistence. We show that the FIPV N protein associates with the RBD-containing region of ZC3HAV1 and that the ZC3HAV1-associated region of N contributes to efficient viral counter-restriction activity. Through coordinated protein–protein and protein–RNA interactions, FIPV N interferes with ZC3HAV1–viral RNA association, thereby supporting viral RNA accumulation and replication. Expression of FIPV N in a heterologous Japanese encephalitis virus system also alleviated ZC3HAV1-mediated RNA-level restriction, indicating that this antagonism activity is functionally transferable and not entirely dependent on FIPV-specific replication machinery. Despite the low CpG content of FIPV RNA, ZC3HAV1 efficiently associated with multiple viral transcripts, suggesting that ZC3HAV1–FIPV RNA recognition is not fully explained by overall CpG abundance and may also be influenced by subgenomic RNA context or structural features. Conclusions: These findings reveal a previously unrecognized mechanism by which a highly pathogenic feline coronavirus circumvents host RNA restriction. By engaging the RBD-containing region of ZC3HAV1 and disrupting ZC3HAV1–viral RNA association, the FIPV N protein effectively attenuates ZC3HAV1-associated antiviral restriction and helps preserve viral RNA accumulation and persistence. This work expands the functional understanding of coronavirus N proteins beyond genome packaging and immune modulation, and provides new insight into FIPV–host interactions that may inform future studies of RNA-level counter-restriction mechanisms in other animal and human coronaviruses. Author summary: Feline infectious peritonitis virus (FIPV) is a deadly coronavirus that causes severe disease in cats and is difficult to treat. One reason FIPV is so challenging to control is its ability to escape the host’s immune response. In this study, we found that FIPV uses its nucleocapsid (N) protein to interfere with a host antiviral protein called ZC3HAV1, which normally helps defend cells by binding to viral RNA and limiting viral RNA accumulation and persistence. We found that ZC3HAV1 can restrict FIPV replication even though FIPV has a low-CpG genome, a feature that might be expected to reduce recognition by a CpG-biased RNA-binding antiviral factor. Instead, ZC3HAV1 association with FIPV RNA appears to be influenced by viral RNA context, including the abundance of certain viral transcripts. Importantly, the FIPV N protein counteracts this restriction by interacting with ZC3HAV1 and disrupting ZC3HAV1–viral RNA association through coordinated protein–protein and protein–RNA interactions. This hijacking of a host defense protein represents a previously unrecognized immune evasion strategy used by FIPV. Our findings provide new insights into how coronaviruses evade RNA-level antiviral restriction and may help inform future studies aimed at identifying antiviral targets.

Related

  1. SARS-CoV-2 maturation driven by a mechano-active nucleocapsid-RNA condensate
    R. Ravindran, B. Guerin, A. Mahmood +14
    bioRxivPreprintAll rights reservedFull textBiophysicsbioRxiv
  2. TOP2A Maintains Heterochromatin Stability by Sustaining LMNB1 Expression to Counteract Senescence.
    Ke Cheng, Yaru Wang, Yueyuan Pan +13
    Aging cellPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
  3. Zinc preserves translational proteostasis to counteract aging and proteotoxicity in Caenorhabditis elegans
    A. Kumar, K. P. Liput, K. Jonak +5
    bioRxivPreprintCC BY-NCFull textMolecular biology & gene regulationbioRxiv
  4. Nucleocapsid-like cryo-EM structure of influenza B virus
    Marie Thirion, Alice Stelfox, Florian Chenavier +8
    PLoS PathogensPeer-reviewedCC BY 4.0Full textStructural biologyGeneral biologyHAL
  5. Variant-specific nucleocapsid mutations shape host innate immune trajectories during SARS-CoV-2 infection
    J. M. Berger, J. M. Schroeder, T. K. Soh +8
    bioRxivPreprintCC BY-NCFull textMolecular biology & gene regulationbioRxiv
BibTeX
@article{zhang2026feline,
  title = {{A feline coronavirus nucleocapsid protein disrupts ZC3HAV1–viral RNA association to counteract host RNA-level restriction}},
  author = {Miao Zhang and Na Li and Kelimujiang Aishanjiang and Aoxing Tang and Meng Zhu and Shiqiang Zhu and Da Zhang and Lingxue Yu and Jie Zhu and Chuanfeng Li and Chunchun Meng and Yingqi Zhu and Guoxin Li and Guangqing Liu},
  journal = {PLOS Pathogens},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.ppat.1014616},
  url = {https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014616},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - A feline coronavirus nucleocapsid protein disrupts ZC3HAV1–viral RNA association to counteract host RNA-level restriction
AU  - Miao Zhang
AU  - Na Li
AU  - Kelimujiang Aishanjiang
AU  - Aoxing Tang
AU  - Meng Zhu
AU  - Shiqiang Zhu
AU  - Da Zhang
AU  - Lingxue Yu
AU  - Jie Zhu
AU  - Chuanfeng Li
AU  - Chunchun Meng
AU  - Yingqi Zhu
AU  - Guoxin Li
AU  - Guangqing Liu
PY  - 2026
DA  - 2026/09/18
JO  - PLOS Pathogens
DO  - 10.1371/journal.ppat.1014616
UR  - https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014616
AB  - Background: Coronaviruses have evolved intricate mechanisms to evade host RNA surveillance systems and sustain efficient replication. The feline infectious peritonitis virus (FIPV), a highly lethal feline coronavirus that causes systemic vasculitis and fatal peritonitis, represents a major challenge in veterinary medicine and serves as a valuable model for studying conserved coronavirus–host interactions. Among coronavirus structural proteins, the nucleocapsid (N) protein not only packages the viral genome but also modulates host antiviral responses, yet its role in counteracting RNA restriction remains incompletely understood. Results: Using co-immunoprecipitation coupled with mass spectrometry screening, we identified the host RNA-binding antiviral factor ZC3HAV1 (also known as ZAP or PARP13) as a prominent N-associated host protein. ZC3HAV1 restricted FIPV replication by associating with viral RNA and reducing viral RNA accumulation and persistence. We show that the FIPV N protein associates with the RBD-containing region of ZC3HAV1 and that the ZC3HAV1-associated region of N contributes to efficient viral counter-restriction activity. Through coordinated protein–protein and protein–RNA interactions, FIPV N interferes with ZC3HAV1–viral RNA association, thereby supporting viral RNA accumulation and replication. Expression of FIPV N in a heterologous Japanese encephalitis virus system also alleviated ZC3HAV1-mediated RNA-level restriction, indicating that this antagonism activity is functionally transferable and not entirely dependent on FIPV-specific replication machinery. Despite the low CpG content of FIPV RNA, ZC3HAV1 efficiently associated with multiple viral transcripts, suggesting that ZC3HAV1–FIPV RNA recognition is not fully explained by overall CpG abundance and may also be influenced by subgenomic RNA context or structural features. Conclusions: These findings reveal a previously unrecognized mechanism by which a highly pathogenic feline coronavirus circumvents host RNA restriction. By engaging the RBD-containing region of ZC3HAV1 and disrupting ZC3HAV1–viral RNA association, the FIPV N protein effectively attenuates ZC3HAV1-associated antiviral restriction and helps preserve viral RNA accumulation and persistence. This work expands the functional understanding of coronavirus N proteins beyond genome packaging and immune modulation, and provides new insight into FIPV–host interactions that may inform future studies of RNA-level counter-restriction mechanisms in other animal and human coronaviruses. Author summary: Feline infectious peritonitis virus (FIPV) is a deadly coronavirus that causes severe disease in cats and is difficult to treat. One reason FIPV is so challenging to control is its ability to escape the host’s immune response. In this study, we found that FIPV uses its nucleocapsid (N) protein to interfere with a host antiviral protein called ZC3HAV1, which normally helps defend cells by binding to viral RNA and limiting viral RNA accumulation and persistence. We found that ZC3HAV1 can restrict FIPV replication even though FIPV has a low-CpG genome, a feature that might be expected to reduce recognition by a CpG-biased RNA-binding antiviral factor. Instead, ZC3HAV1 association with FIPV RNA appears to be influenced by viral RNA context, including the abundance of certain viral transcripts. Importantly, the FIPV N protein counteracts this restriction by interacting with ZC3HAV1 and disrupting ZC3HAV1–viral RNA association through coordinated protein–protein and protein–RNA interactions. This hijacking of a host defense protein represents a previously unrecognized immune evasion strategy used by FIPV. Our findings provide new insights into how coronaviruses evade RNA-level antiviral restriction and may help inform future studies aimed at identifying antiviral targets.
SN  - 1553-7374
ER  -